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Porcine endogenous retroviruses (PERV) have been shown to have zoonotic potential, both in vitro and in vivo. Once
integrated into the host cell genome activation of the proviral genes is ultimately dependent upon transactivation of the long
terminal repeat (LTR). Currently there is no direct evidence of host cell transcription factors interacting with PERV LTRs.
Using comparative genomics we discovered a potentially functional single nucleotide polymorphism (SNP) within the U5
region downstream of the TATA box in the PERV LTR that distinguishes PERV A from PERV B and PERV C subtypes. We
demonstrated that the SNP occurs within a potential hormone-responsive region where it has a profound effect, not only
upon estrogen receptor binding but also upon the binding of other transcription factors at this site. These results suggest
that differences in transcriptional regulation between PERV subtypes are subtle and, as for other retroviruses, transcription
can be mediated by steroid hormone receptors. © 2001 Academic Press
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In recent years the number of candidates waiting for
organ transplantation has dramatically outpaced the
supply of human organs available, leading to a renewed
interest in pig to human xenotransplantation as an alter-
native (Auchincloss and Sachs, 1998). However, safety
concerns over the risk of xenozoonosis, particularly with
regard to porcine endogenous retroviruses (PERV), have
been raised (Weiss, 1998; Gunzburg and Salmons, 2000).
Studies carried out on humans treated with living pig
tissue have not found any evidence of infection from
PERV (Heneine et al., 1998; Patience et al., 1998; Paradis
et al., 1999; Dinsmore et al., 2000). These studies have
included patients with a range of exposure routes to pig
tissues, including skin grafts, transplantation with por-
cine pancreatic islets, and extracorporeal liver and
splenic perfusion. Monitoring for infection in these cases
was predominantly peripheral blood mononuclear cell-
and serum-based. Moreover, examination of primates
transplanted with pig organs has also shown an ab-
sence of infection with PERV despite the analysis of
multiple tissue types (Martin et al., 1998; Heneine et al.,
1998). Nevertheless, it has been demonstrated that both
human and nonhuman primate cells can become in-
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83fected with PERV in vitro (Patience et al., 1997; Blusch et
al., 2000). Furthermore, recent observations that multiple
compartments in a SCID mouse transplanted with pig
islets could be infected by PERV has raised concerns
that PERV could be spread in vivo by a cell-to-cell route
(van der Laan et al., 2000) and in the absence of micro-
chimerism (Deng et al., 2000).
Human recipients of porcine material are rare and
offer limited biopsy potential and there are a number of
difficulties associated with establishing in vivo models
for the study of PERV infectivity from the point of view of
estimating zoonotic risk potential. Nonhuman primate
models are expensive, time consuming, and lack opti-
mized immunosuppressive regimes at present. It is
therefore advantageous to establish biologically relevant
in vitro models in order to expand our understanding of
PERV expression in response to various stimuli, leading
to infection of naı¨ve cells and zoonosis. Indeed in vitro
relative infectivity studies have already been carried out
on cell types from various species (Wilson et al., 2000).
Based on our current knowledge of the C-type retrovirus
life cycle we know the mechanisms of virus replication,
integration, packaging, and indeed infection, although
the PERV receptor remains to be identified.
To date there are no published data concerning the
molecular mechanisms of PERV long terminal repeat
(LTR) transactivation. There are, however, a number of
PERV LTR sequences accessible via GenBank as well as
a collection of novel unique PERV proviral sequences
available to us following our genome-wide screening of
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84 QUINN AND LANGFORDthe Large White pig for these potential zoonotic agents
(unpublished data). In broad terms there have been three
categories of PERV identified, A, B, and C, originally
defined on the basis of receptor tropism by interference
assays (Takeuchi et al., 1998). This variable tropism re-
sults from polymorphism in the env open reading frame
ncoding the receptor-binding envelope protein. The re-
aining gag and pol genes are comparatively highly
onserved amongst subtypes. However, subsequent
tudies by our lab (Herring et al., 1999) have demon-
trated that significant heterogeneity also exists within
he LTR regions of these PERVs and has led to the further
ubclassification of subtypes on the basis of this LTR
olymorphism, e.g., PERV C1.
The cellular transcription factors that modulate PERV
ene expression from the LTR of the integrated PERV
rovirus remain undiscovered. Yet an understanding of
he role of these factors may hold the key to predicting
hich cells and tissues are most likely to support the
roduction of infectious PERV in vivo.
In this report we have explored the biological signifi-
ance of a single nucleotide polymorphism (SNP) within
hitherto unidentified putative hormone-responsive re-
ion (HRR) of the PERV LTR. We first identified the puta-
ive HRR in silico using comparative genomics, then
characterized the effect of the SNP upon protein interac-
tions within this region by electrophoretic mobility shift
assay (EMSA). This report provides an example of ap-
plied bioinformatics in establishing structure/function re-
lationships within genomics research.
RESULTS
Genomic analysis of HRR of PERV LTRs
Genomic comparisons of PERV A and B LTRs from
multiple proviral clones revealed a striking subtype-re-
stricted single nucleotide polymorphism in the U5 region
downstream of the TATA box (Fig. 2). Moreover the PERV
C variant was consistently identical to PERV B at the SNP
site. We selected an arbitrary 36-bp region surrounding
the SNP site and searched for potential transcription
factor binding sites using PatSearch (version 1.1) as de-
scribed under Materials and Methods. According to the
significance levels of the application this region showed
homology to a number of imperfect and overlapping
hormone-response elements (HRE) with the SNP occu-
pying a pivotal position in all of them (Fig. 1). We also
observed that as a result of one nucleotide change at the
SNP site, the three putative overlapping HREs present in
the PERV A LTR are reduced to one potential site in the
LTR of B and C subtypes. This region will subsequently
be referred to as the hormone-response region.
The sequence AGAACAnnnTGTTCT comprises the
consensus binding site for the hormone receptors (HR),
glucocorticoid receptor (GR), androgen receptor (AR),
mineralocorticoid receptor (MR), and progesterone re-ceptor (PR), with a small variation in this sequence
shown to be optimal for binding of estrogen receptor
(ER): AGGTCAnnnTGACCT. In reality, however, few con-
sensus HRE exist in the regulatory regions of hormone-
responsive genes, but instead steroid regulation of gene
expression is mediated by various “loose” or imperfect
HREs. Since many hormone-responsive genes are tissue
specific it is believed that such degeneracy is one mech-
anism for conferring receptor-type specificity, and hence
tissue specificity, on gene expression. More importantly,
perhaps, this flexibility allows for overlap with cis-ele-
ments for a multitude of non-HR transcription factors that
may or may not themselves be tissue specific (Akerblom
et al., 1988). This phenomenon, which facilitates the
formation of hormone receptor-dependent transcription
complexes, is well documented not only for many eu-
karyotic genes but also for proviral LTRs (Truss et al.,
1996; Adler et al., 1993).
As shown in Fig. 1 the PERV B/C hormone-response
region (HRR) contains a single imperfect estrogen-re-
sponsive element (ERE) with the SNP located in the
linker region separating the half-sites. It is only the
length of this trinucleotide linker, not the precise se-
FIG. 1. SNP in LTR confers multiple overlapping imperfect HREs on
class A but not on class B and C PERVs. The SNP is indicated in
lowercase for PERV B/C LTRs (identical for both B and C subtypes and
comprises one putative HRE (ERE)) and PERV A LTR (SNP within three
putative HREs). Both PERV B/C and PERV A share a common HRE
(EREB and EREA) due to the location of an SNP within the trinucleotide
linker sequence. PERV A LTR contains a second putative ERE (EREA2)
and an imperfect canonical HRE that are both absent from PERV B/C
LTRs.quence, that is important for receptor binding (Beato,
1989). Therefore this ERE is also present in PERV A.
sT under M
cates th
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putative ERE, EREA2, in which the SNP is situated in one
of the ERE half-sites. In contrast the PERV B/C SNP
sequence does not theoretically support an ERE at this
site. For PERV A there is overlap with yet another HRE
within this HRR, which again is dependent upon the
sequence of the SNP. This site is also absent in the HRR
of PERV B/C LTRs.
Next we compared this 36-bp HRR with a range of
other retroviral LTRs, some of which, e.g., the mouse
mammary tumor virus (MMTV) and murine endogenous
retrovirus (MUeRV), are known to be hormone respon-
sive. Significant homology was found with LTRs from
various HERVs, MMTV, and MUeRV (data not shown). In
Fig. 2 the arrows indicate the half-sites of the putative
EREs described in Fig. 1. The shaded box shows the
SNP. We found that key nucleotides are conserved
across multiple ERVs within these EREs as shown by the
asterisks. Moreover the juxtaposition of the putative HRR
with respect to the TATA box is also significantly con-
erved (the TATA box for this full-length HERV clone
(GenBank Accession No. AF260249) is derived from
alignment with multiple characterized partial HERV LTRs
with known TATA box locations) (Sjottem et al., 1996). The
LTR of the murine endogenous retrovirus is highly ho-
FIG. 2. Alignment of LTRs from various retroviruses demonstrating s
he GenBank accession numbers for each of the sequences are given
boxes for PERVs/MUeRV and HERV, respectively. The hatched box indi
EREA2 half-sites, respectively.mologous overall to PERV both within and surrounding
the PERV HRR. It is noteworthy that the juxtaposition ofthe HRR with respect to the TATA box (boxed region, Fig.
2) is virtually identical in the LTRs of both proviruses.
However, although functional HREs elsewhere in the LTR
of the MUeRV have been identified, this putative HRR has
yet to be characterized and, in the light of the data
presented in this paper, may play a role in steroid-
regulated gene expression.
This homology with hormone-responsive regions of
other endogenous retroviruses and the occurrence of an
SNP within overlapping putative HREs in the PERV LTR
suggest two things. First, PERV expression and ulti-
mately production of infectious virus may be hormonally
regulated. Second, subtypes of PERV may be regulated
differently among various cell types in different tissues
and organs as a result of sequence variation at a single
nucleotide position, resulting in distinct transcription fac-
tor binding potential.
Analysis of hormone receptor interaction with HRR
To establish a molecular basis for the theoretical po-
tential of the PERV HRR to bind HRs and non-HR tran-
scription factors, and to furthermore establish a clear
difference in binding potential between PERV subtypes A
vs B/C based on the SNP alone, we performed a set of
nt homology with putative HRR of PERV in hormone-responsive LTRs.
aterials and Methods. Boxed areas indicate known and putative TATA
e SNP. The solid and broken-line arrows indicate the EREA/EREB andignificaElectrophoretic Mobility Shift Assays (EMSA).
Nuclear extracts from a range of human and rat cell
H
t racts. H
c
86 QUINN AND LANGFORDtypes known to express one or more subclass of HR
were chosen to obtain a generalized impression of DNA–
protein interactions around the HRR. T47D cells express
both PR and ER, MCF-7 cells express ER, and Raji cells
express GR. We speculated that rat liver cells would
express rat GR; however, the relative contributions made
by different rat liver cell types in the nuclear extract was
not known. The HRR is referred to here as probe A or
probe B, corresponding to the 36-bp HRR found in PERV
A and PERV B/C LTRs, respectively.
While GR is almost ubiquitously expressed other HRs
such as AR and ER are more tissue-restricted. It is
known that the mammary carcinoma cell lines T47D and
MCF-7 both express the ER and were chosen on the
basis of our preliminary genomic analysis suggesting
the existence of EREs in the HRR and a possible SNP-
dependent difference in ER binding in this region (Fig. 1).
At this point it is clear that probes A and B have
different protein binding potentials (Fig. 3). For probe B
the SNPB-specific complex is unique to probe B and was
formed with all cell types tested, although MCF-7
showed the strongest interaction (Fig. 3, lane 11). The
effect of estradiol (E2), an agonist of ERs (both a and b),
FIG. 3. EMSA showing protein interactions in the HRR of PERV LTRs
RR containing the SNP from PERV A and PERV B/C subtypes, respect
ypes indicated above each lane. Free Probe contained no nuclear ext
omplex; N/S, nonspecific complex.was dramatic in MCF-7-treated cells. For probe A com-
plex HR was enhanced along with the E-I (estrogen-inducible) complex. For probe B there was less enhance-
ment of the HR complex upon E2 treatment; however, the
SNPB-specific complex was abolished completely and
the E-I complex, hardly detectable in MCF-7 (2E2) cells,
was strongly induced either directly or indirectly by E2-
mediated signal transduction (Fig. 3, lane 12).
Identification of HR–HRR complexes for PERV A
A set of competition EMSAs was set up using nuclear
extracts from MCF-7 cells with or without E2 treatment.
HR binding within the HRR was assayed using a short
unlabeled double-stranded oligonucleotide correspond-
ing to the consensus HRE and compared with the puta-
tive EREA and EREB (Fig. 1). Since we know that the ER
gene is autoregulated (Lazennec et al., 1996) and two of
our complexes (HR and E-I complex) were enhanced
upon E2 treatment, it seemed plausible that one of these
complexes contained ER. By extension this suggests the
existence of a functional ERE within the PERV HRR. The
HR complex was specifically competed by the canonical
unlabeled HRE oligonucleotide (Fig. 4a, lane 8), confirm-
ing that this complex comprised HR and more specifi-
ariety of cell types. SNP A and B probes represent the 36-bp putative
adiolabeled probes were incubated with nuclear extracts from the cell
R, hormone receptor–DNA complex; E-I Complex, estrogen-induciblein a v
ively. Rcally ER (due to the E2-inducibility of this complex (Fig.
4a, lanes 3 and 8)). This was further confirmed by per-
LTR and nuclear extracts from MCF-7 cells. A 10-fold molar excess of
unlabeled double-stranded oligonucleotide corresponding to EREA,
a
t
d
87ESTROGEN RECEPTOR BINDING AFFINITIES OF PERV SUBTYPESforming the EMSA using the consensus HRE oligonucle-
otide as a labeled probe (Fig. 4a, lanes 6 and 11). When
EREA was used as a competitor the HR complex per-
sisted while the E-I complex was competed efficiently.
The same result was seen when the EREB competitor
was used in a similar reaction (Fig. 4a, lanes 4 and 9, 5
and 10). These results suggested that the E-I complex
was interacting with the EREA/EREB indiscriminately but
this complex could not interact with the canonical HRE.
Moreover the inability of EREA or EREB to efficiently
compete for ER binding is compatible with our assump-
tion that the PERV A HRR contains a second ERE, EREA2,
which is sufficiently distant from EREA so as not to be
affected by either EREA or EREB competitors. Thus, the
persistence of the HR complex in Fig. 4a in the presence
of EREA or EREB competitors may reflect a shift in the
bias of ER binding from EREA towards EREA2 that is
unnoticeable on the gel since the mobility of both com-
plexes is identical.
Identification of HR–HRR complexes for PERV B/C
In the analysis of ER interaction with probe A we
concluded that there were two EREs involved in the
receptor binding and therefore we could not compete
this complex using EREA/EREB competitor. If true then
we would not expect to see the same competition pattern
in a similar experiment involving probe B, since there is
only one putative ERE, EREB, present in the PERV B/C
HRR. In Fig. 4b we can clearly see that this is the case.
As for probe A, the canonical HRE competes specifically
for ER binding (Fig. 4b, lane 3). But unlike probe A, and as
predicted for probe B, the ER–HRR complex is also com-
peted using both EREA and EREB (Fig. 4b, lanes 4 and 5),
confirming that this region is the one and only site of ER
interaction within the PERV B/C HRR. However, the im-
pact of the SNP on DNA–protein interactions between
PERV subtypes is yet more pronounced. For probe B the
E-I complex can no longer be competed using EREA/
EREB, indicating that this complex has a stronger affinity for
probe B than for probe A (Fig. 4b, lanes 9 and 10). In
addition we can further confirm the SNP sequence speci-
ficity of the SNPB-specific complex because it can be com-
peted using only EREB and not EREA (Fig. 4b, lane 5 vs 4).
EREB, and HRE as shown in Fig. 1 was used to demonstrate specificity
of ER binding to HRR (lanes 3 and 8, 4 and 9, 5 and 10). Labeled HRE
oligonucleotide was used as a probe to verify the identity of HR protein
complex (lanes 6 and 11). (b) DNA–protein interactions between the
HRR of PERV B/C LTRs and nuclear extracts from MCF-7 cells. SNPB-
specific complex cannot be generated with the probe A SNP. Also it
cannot be competed by an excess of cold probe A SNP (lane 4 vs lane
5). The ER complex can be competed with EREA and EREB as well as
HRE. (c) Immunological analysis of HR–DNA complexes. Anti-ERa, -GR,
nd -PR antisera, but not control antisera, abrogate HR–DNA interac-FIG. 4. (a) DNA–protein interactions between the HRR of the PERV A
ions with both the SNPA and the HRE probes in nuclear extracts
erived from MCF-7 cells.
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88 QUINN AND LANGFORDImmunological analysis of HR–DNA complexes
To further demonstrate the identity of the HR–SNP and
HR–HRE complexes we used antibodies specific for
ERa, GR, and PR to partially block the interaction be-
ween the respective HR and its DNA binding site. In
uclear extracts derived from untreated MCF-7 cells,
R–DNA complex formation was partially abrogated, in a
ime-dependent manner, by anti-ER, anti-GR, and anti-PR
ntisera, but not by the rabbit serum control (Fig. 4c).
DISCUSSION
There are many precedents for hormone-dependent
TR transactivation in the literature. Steroid hormones
ediate both LTR activation, e.g., Moloney Murine Sar-
oma virus (MoMSV) (Miksicek et al., 1986), MMTV (Pay-
ar et al., 1983; Truss et al., 1996), MUeRV (Ramakrish-
an and Robins, 1997), and suppression of transcription:
MTV (Boronat et al., 1997), and HIV (Mitra et al., 1995).
n this report we present evidence for the potential role of
teroid hormone receptors, in particular the estrogen
eceptor, in the regulation of PERV gene expression.
urthermore on the basis of the existing classification of
ERV subtypes there is a clear difference in the trans-
ctivation potential of PERV A vs PERV B/C subtypes as
result of a single nucleotide polymorphism, as deter-
ined by EMSA. Compared with LTRs from different
etroviruses the PERV LTR shows highest homology
verall with the MUeRV imposon1 59 LTR (GenBank Ac-
ession No. MMU95781). This is the provirus upstream
f the mouse sex-limited protein (slp) gene and provides
n intriguing example of a mammalian retrotransposon
hat has become heritably associated with cellular gene
egulation (Stavenhagen and Robins, 1988). The andro-
en specificity of this enhancer is striking and involves
unctional synergism between multiple androgen-re-
ponsive element-like sequences and binding sites for
ther transcription factors. However, altering the orien-
ation or mutating one of these HREs allows GR to
unction, suggesting that GR is repressed by juxtaposi-
ion to particular factors within the androgen-specific
omplex. The presence of such regulatory systems may
ccount for several instances of sexually dimorphic gene
xpression in rodents and may indeed be capable of
mposing sexual dimorphism upon PERV expression in
ther species. Moreover, the region of MMTV homolo-
ous to the PERV HRR contains multiple glucocorticoid-
esponsive elements (Xu et al., 1994; this report-data not
hown). The pattern of conserved nucleotides across
arious species of ERV around the SNP is curiously
ompatible with the existence of HREs (Fig. 2, arrows),
articularly EREA/EREB (Fig. 2, solid arrows), within the
utative HRR and points to the potential functional im-
ortance of this region. This may form a molecular basisor the observation made by Ono et al. (1987) that T47D
ells treated with estradiol display an upregulation in
s
qERV-K gene expression, which furthermore suggests a
ole for female steroid hormones in PERV gene expres-
ion.
The HRR region of PERV A appears to contain two
utative EREs. Our data suggest that both elements bind
R. In contrast the HRRs of PERV B/C subtypes contain
ne putative ERE. Both of these theoretical observations
re supported by the EMSA data. Supershift experiments
ndicate that three hormone receptors (ER, GR, and PR)
an bind to SNPA (Fig. 4c), while the consensus ERE
AGGTCAnnnTGACCT), which differs slightly from the
onsensus HRE (AGAACAnnnTGTTCTA), can specifically
ompete out the HR–SNPA complex (data not shown). A
ighly interesting finding is the variation in non-HR tran-
cription factor binding between the HRR of PERV sub-
ypes. These findings highlight the significance of HR
ooperation with coactivator proteins to direct gene ex-
ression and how great the impact of a single base
hange is upon the interaction of such coactivators with
he HR within the HRR. It is known that ER interacts with
he coactivator AIB1 in MCF-7 cells (Tikkanen et al.,
000) and both in vivo and in vitro with LIM/homeodo-
ain protein islet-1 (Gay et al., 2000). Additionally, it has
een shown that interaction between ER and MCF-7
ell-specific transcription factors occurs to drive high
xpression from the trout ER gene promoter in MCF-7
ells (Lazennec et al., 1996). ER could also behave as an
interfering receptor” to attenuate PERV expression (Ban-
al and Latchman, 1990). Activated ER complex has been
hown to inhibit transcriptional activity of the activated
R complex within the MMTV LTR (Kumar et al., 1994),
nd it is believed that there is interaction between AR
nd ER in the pathogenesis of benign prostatic hyper-
lasia (Coffey and Walsh, 1990). Clearly, additional ex-
eriments are required to identify the non-HR transcrip-
ion factors involved in the binding of the PERV HRR and
o study the biological consequences of HR interactions
ith the PERV LTR. This may provide a novel system for
he study of HR/ER-regulated gene expression.
SNPs in genes and regulatory elements have recently
ecome a powerful tool for the diagnosis of hereditary
isorders in humans (Gould Rothberg et al., 2000). Here
e have identified a SNP within the regulatory region of
he PERV provirus with apparent biological significance.
urrently there is limited knowledge of the distribution
atterns of PERV expression throughout the pig. It has
een observed that some subtypes of PERV, i.e., PERV C,
ppear less infectious than others (Takeuchi et al., 1998).
oreover, there are experimental data demonstrating
ifferences in infectivity between PERVs from Large
hite and miniswine (Deirdre Cunningham, unpublished
bservation). Taken together these results indicate that
hile infectious heterogeneity among PERVs may be
ttributable to receptor tropism, it may also have a tran-
criptional basis originating from variations in LTR se-
uence and transcription factor binding potential. The
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89ESTROGEN RECEPTOR BINDING AFFINITIES OF PERV SUBTYPESdata presented in this paper suggest that analysis of LTR
activity will contribute significantly to our understanding
of the potential risks of xenozoonosis associated with
PERV.
MATERIALS AND METHODS
Annealing and labeling of oligonucleotide probes
Complementary oligonucleotides (Table 1) were an-
nealed by mixing 2 nmol of each oligonucleotide in 100
ml 13 PCR buffer (Perkin–Elmer), heating to 95°C for 5
in, and cooling gradually over a 2-h period to 20°C.
nnealing reactions were maintained at 20°C overnight.
en microliters of annealed oligonucleotides with 59
oly(G) overhangs were labeled with [32P]CTP using the
Megaprime random-prime labeling kit (Amersham Phar-
macia Biotech).
EMSA
EMSAs were set up by mixing 3 ml of 53 buffer (20%
glycerol, 100 mM Tris, pH 8.0, 300 mM KCl, 25 mM MgCl2,
500 mg/ml BSA, 5 mM dithiothreitol), 0.75 ml poly(dI z dC)
(Sigma), 1 ml purified labeled probe (50,000 cpm), and
H2O to 15 ml (minus volume of 10 mg nuclear extract).
eactions were mixed and 10 mg of nuclear extract was
dded and reactions were incubated at 20°C for 25 min.
or competition experiments, 10-fold molar excess of
nlabeled competitor double-stranded DNA was added
oincident with the labeled probe. For supershift exper-
ments, rabbit anti-human hormone receptor-specific
olyclonal antibodies (anti-ERa, sc-543; anti-GR, sc-1003;
and anti-PR, sc539; Santa Cruz Biotechnologies, Santa
Cruz, CA) were added to bandshift reactions, in quanti-
ties recommended by the manufacturer, and incubated
TABLE 1
Oligonucleotides Used to Generate Probes and Unlabelled
Competitors for EMSAs
BS1sense LTRsnpA GGGGTTTGCATCAAGACCGCTTC-
TTGTGAGTGATTTGGG
BS1antisense LTRsnpA GGGGCCCAAATCACTCACAAGAA-
GCGGTCTTGATGCAAA
BS1sense LTRsnpB GGGGTTTGCATCAAGACCGCTTCT-
CGTGAGTGATTTGGG
BS1antisense LTRsnpB GGGGCCCAAATCACTCACGAGAA-
GCGGTCTTGATGCAAA
HREsense GGGGGAGTACAGAGTGTTCTCC
HREantisense GGGGGAGAACACTCTGTACTCC
REsnpAsense GGGGGACCGCTTCTTGTGAGCC
REsnpAantisense GGGGGCTCACAAGAAGCGGTCC
REsnpBsense GGGGGACCGCTTCTCGTGAGCC
REsnpBantisense GGGGGCTCACGAGAAGCGGTCC
Note. All annealed oligonucleotides were designed to have poly(G)
verhangs to facilitate [32P]dCTP labeling using Klenow.for 45 min at 20°C. For control reactions, rabbit preim-
mune serum was added. Following incubation, 3 ml 53 BHi-Density TBE sample buffer (Novex) was added to the
reaction and the sample was immediately resolved on a
prerun precast 6% DNA retardation gel (Novex) in 0.53
TBE running buffer (Novex). Gels were run for 60–90 min
at 100 V at 4°C, dried overnight using the Dry Ease Gel
Drying System (Novex), exposed for 1–5 h, and analyzed
using a Molecular Dynamic Storm phosphorimager or
exposed overnight using Kodak Biomax MR single-emul-
sion film.
Nuclear extracts
For all experiments the nuclear extracts used were
obtained from Geneka Biotechnology, Inc. (Canada).
T47D and MCF-7 are human breast carcinoma cell lines
and Raji is a human Burkitt’s lymphoma cell line. MCF-
7 1 E2 nuclear extracts were derived from cells treated
with 1 nM E2 for 96 h.
Bioinformatics of PERV LTR sequences
The 36-bp region surrounding the SNP site was
searched for potential transcription factor binding sites
using PatSearch (version 1.1) with TRANSFAC 3.5 and
TRRD 3.5 sites against the Consensi library with mini-
mum match window set to 6 and the output threshold set
to 5 (GBF, Brunswick, Germany). The URL for this facility
is http//transfac.gbf.de. This bioinfomatics portal has
been validated in previous studies (Wingender et al.,
2000). Comparative genomics between endogenous ret-
roviral LTRs from different species was carried out on the
Novartis RIM bioinformatics portal using the Biobench
interface. Multiple alignments shown were generated
using ClustalW (version 1.7). GenBank accession num-
bers for the LTR sequences shown in Fig. 2 are PERV A,
AJ133817; PERV B, AJ133818; PERV C, AF038599; HERV,
AF260249; MMTV, L11749; and MUeRV, U95781.
ACKNOWLEDGMENT
We are grateful to Dr. Clive Patience (Immerge Biotherapeutics, Inc.)
for his critical comments on the manuscript, and Xose´ Fernandez-
Suarez for assistance with Bioinformatics.
REFERENCES
Adler, A. J., Scheller, A., and Robins, D. M. (1993). The stringency and
magnitude of androgen-specific gene activation are combinatorial
functions of receptor and nonreceptor binding site sequences. Mol.
Cell. Biol. 13, 6326–6335.
Akerblom, I. E., Slater, E. P., Beato, M., Baxter, J. D., and Mellon, P. L.
(1988). Negative regulation by glucocorticoids through interference
with a cAMP responsive enhancer. Science 241, 350–353.
Auchincloss, H., Jr., and Sachs, D. H. (1998). Xenogeneic transplanta-
tion. Annu. Rev. Immunol. 16, 433–470.
Bansal, G. S., and Latchman, D. S. (1990). Oestrogen enhances the
responsiveness of the MMTV-LTR to glucocorticoid in ZR-75-1 hu-
man breast cancer cells. J. Steroid Biochem. 36, 399–405.
eato, M. (1989). Gene regulation by steroid hormones. Cell 56, 335–
344.
lusch, J. H., Patience, C., Takeuchi, Y., Templin, C., Roos, C., Von Der
BC
v
W
W
W
X
90 QUINN AND LANGFORDHelm, K., Steinhoff, G., and Martin, U. (2000). Infection of nonhuman
primate cells by pig endogenous retrovirus. J. Virol. 74, 7687–7690.
oronat, S., Richard-Foy, H., and Pina, B. (1997). Specific deactivation of
the mouse mammary tumor virus long terminal repeat promoter upon
continuous hormone treatment. J. Biol. Chem. 272, 21803–21810.
offey, D. S., and Walsh, P. C. (1990). Clinical and experimental studies
of benign prostatic hyperplasia. Urol. Clin. North Am. 17, 461–475.
Deng, Y. M., Tuch, B. E., and Rawlinson, W. D. (2000). Transmission of
porcine endogenous retroviruses in severe combined immunodefi-
cient mice xenotransplanted with fetal porcine pancreatic cells.
Transplantation 70, 1010–1016.
Dinsmore, J. H., Manhart, C., Raineri, R., Jacoby, D. B., and Moore, A.
(2000). No evidence for infection of human cells with porcine endog-
enous retrovirus (PERV) after exposure to porcine fetal neuronal
cells. Transplantation 70, 1382–1389.
Gay, F., Anglade, I., Gong, Z., and Salbert, G. (2000). The LIM/homeodo-
main protein islet-1 modulates estrogen receptor functions. Mol.
Endocrinol. 14, 1627–1648.
Gould Rothberg, B. E., Ramesh, T. M., and Burgess, C. E. (2000).
Integrating expression-based drug response and SNP-based phar-
macogenetic strategies into a single comprehensive pharmacog-
enomics program. Drug Dev. Res. 49, 54–64.
Gunzburg, W. H., and Salmons, B. (2000). Xenotransplantation: Is the
risk of viral infection as great as we thought? Mol. Med. Today 6,
199–208.
Heneine, W., Tibell, A., Switzer, W. M., Sandstrom, P., Rosales, G. V.,
Mathews, A., Korsgren, O., Chapman, L. E., Folks, T. M., and Groth,
C. G. (1998). No evidence of infection with porcine endogenous
retrovirus in recipients of porcine islet-cell xenografts. Lancet 352,
695–699.
Herring et al. (1999). In “5th International Congress on Xenotransplan-
tation,” abstract 1153.
Kumar, M. V., Leo, M. E., and Tindall, D. J. (1994). Modulation of
androgen receptor transcriptional activity by the estrogen receptor. J.
Androl. 15, 534–542.
Lazennec, G., Kern, L., Salbert, G., Saligaut, D., and Valotaire, Y. (1996).
Cooperation between the human estrogen receptor (ER) and MCF-7
cell-specific transcription factors elicits high activity of an estrogen-
inducible enhancer from the trout ER gene promoter. Mol. Endocri-
nol. 10, 1116–1126.
Martin, U., Steinhoff, G., Kiessig, V., Chikobava, M., Anssar, M., Mor-
schheuser, T., Lapin, B., and Haverich, A. (1998). Porcine endogenous
retrovirus (PERV) was not transmitted from transplanted porcine
endothelial cells to baboons in vivo. Transplant. Int. 11, 247–251.
Miksicek, R., Heber, A., Schmid, W., Danesch, U., Posseckert, G., Beato,
M., and Schutz, G. (1986). Glucocorticoid responsiveness of the
transcriptional enhancer of Moloney murine sarcoma virus. Cell 46,
283–290.
Mitra, D., Sikder, S. K., and Laurence, J. (1995). Role of glucocorticoid
receptor binding sites in the human immunodeficiency virus type 1
long terminal repeat in steroid-mediated suppression of HIV gene
expression. Virology 214, 512–521.Ono, M., Kawakami, M., and Ushikubo, H. (1987). Stimulation of expres-
sion of the human endogenous retrovirus genome by female steroidhormones in human breast cancer cell line T47D. J. Virol. 61, 2059–
2062.
Paradis, K., Langford, G., Long, Z., Heneine, W., Sandstrom, P., Switzer,
W. M., Chapman, L. E., Lockey, C., Onions, D., and Otto, E. (1999).
Search for cross-species transmission of porcine endogenous ret-
rovirus in patients treated with living pig tissue. Science 285, 1236–
1241.
Patience, C., Patton, G. S., Takeuchi, Y., Weiss, R. A., McClure, M. O.,
Rydberg, L., and Breimer, M. E. (1998). No evidence of pig DNA or
retroviral infection in patients with short-term extracorporeal connec-
tion to pig kidneys. Lancet 352, 699–701.
Patience, C., Takeuchi, Y., and Weiss, R. A. (1997). Infection of human
cells by an endogenous retrovirus of pigs. Nat. Med. 3, 282–286.
Payvar, F., DeFranco, D., Firestone, G. L., Edgar, B., Wrange, O., Okret,
S., Gustafsson, J. A., and Yamamoto, K. R. (1983). Sequence-specific
binding of glucocorticoid receptor to MTV DNA at sites within and
upstream of the transcribed region. Cell 35, 381–392.
Ramakrishnan, C., and Robins, D. M. (1997). Steroid hormone respon-
siveness of a family of closely related mouse proviral elements.
Mamm. Genome 8, 811–817.
Sjottem, E., Anderssen, S., and Johansen, T. (1996). The promoter
activity of long terminal repeats of the HERV-H family of human
retrovirus-like elements is critically dependent on Sp1 family proteins
interacting with a GC/GT box located immediately 39 to the TATA box.
J. Virol. 70, 188–198.
Stavenhagen, J. B., and Robins, D. M. (1988). An ancient provirus has
imposed androgen regulation on the adjacent mouse sex-limited
protein gene. Cell 55, 247–254.
Takeuchi, Y., Patience, C., Magre, S., Weiss, R. A., Banerjee, P. T., Le
Tissier, P., and Stoye, J. P. (1998). Host range and interference studies
of three classes of pig endogenous retrovirus. J. Virol. 72, 9986–9991.
Tikkanen, M. K., Carter, D. J., Harris, A. M., Le, H. M., Azorsa, D. O.,
Meltzer, P. S., and Murdoch, F. E. (2000). Endogenously expressed
estrogen receptor and coactivator AIB1 interact in MCF-7 human
breast cancer cells. Proc. Natl. Acad. Sci. USA 97, 12536–12540.
Truss, M., Bartsch, J., Mows, C., Chavez, S., and Beato, M. (1996).
Chromatin structure of the MMTV promoter and its changes during
hormonal induction. Cell. Mol. Neurobiol. 16, 85–101.
an der Laan, L. J., Lockey, C., Griffeth, B. C., Frasier, F. S., Wilson, C. A.,
Onions, D. E., Hering, B. J., Long, Z., Otto, E., Torbett, B. E., and
Salomon, D. R. (2000). Infection by porcine endogenous retrovirus
after islet xenotransplantation in SCID mice. Nature 407, 90–94.
eiss, R. A. (1998). Retroviral zoonoses. Nat. Med. 4, 391–392.
ilson, C. A., Wong, S., VanBrocklin, M., and Federspiel, M. J. (2000).
Extended analysis of the in vitro tropism of porcine endogenous
retrovirus. J. Virol. 74, 49–56.
ingender, E., Chen, X., Hehl, R., Karas, H., Liebich, I., Matys, V.,
Meinhardt, T., Pruss, M., Reuter, I., and Schacherer. (2000). TRANS-
FAC: An integrated system for gene expression regulation. Nucleic
Acids Res. 28, 316–319.
u, L., Haga, S., Imai, S., and Sarkar, N. H. (1994). Cloning in a plasmid
of an MMTV from a wild Chinese mouse: Sequencing of the viral LTR.
Virus Res. 33, 167–178.
